{"id":"W2091264926","doi":"10.1111/j.1365-2141.2010.08387.x","title":"Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Clofarabine; Medicine; Cytarabine; Internal medicine; Refractory (planetary science); Nucleoside analogue; Fludarabine; Oncology; Regimen; Gastroenterology; Chemotherapy; Nucleoside; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002120505,0.0002860163,0.002220821,0.000421793,0.0001341214,0.00003641423,0.0003698416,0.0005003003,0.0002041206],"category_scores_gemma":[0.003142233,0.0002504231,0.0003067627,0.0002812046,0.0007210593,0.0001915458,0.0001410077,0.001033864,0.000005701528],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002629687,"about_ca_system_score_gemma":0.01227651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000553979,"about_ca_topic_score_gemma":0.001099455,"domain_scores_codex":[0.9961395,0.0003124361,0.001895178,0.0004362175,0.000593227,0.0006234157],"domain_scores_gemma":[0.9958457,0.001424488,0.001067252,0.0004351665,0.0007552941,0.0004721028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6380743,0.01440316,0.0003750248,0.001041516,0.002985241,0.2296315,0.001692011,0.00000321795,0.03319427,0.0002645764,0.007382506,0.07095263],"study_design_scores_gemma":[0.5507755,0.0402341,0.0001520994,0.0002278473,0.0009766091,0.4012467,0.0005894339,0.0004069376,0.0008167915,0.0001315103,0.004256583,0.0001859061],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950798,0.0008520437,0.0002343299,0.000353974,0.001164403,0.002135586,0.00005193999,0.0000235631,0.0001043828],"genre_scores_gemma":[0.9951298,0.0006978422,0.002971125,0.0001750162,0.0005696701,0.00008628649,0.00002195812,0.00006784611,0.000280492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1716152,"threshold_uncertainty_score":0.9999948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02900181210569678,"score_gpt":0.3794796022563477,"score_spread":0.3504777901506509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}